GCMCX
Price
$29.29
Change
+$0.09 (+0.31%)
Updated
Jul 9 closing price
Net Assets
1.09B
VIMSX
Price
$77.34
Change
+$0.33 (+0.43%)
Updated
Jul 9 closing price
Net Assets
192.45B
Interact to see
Advertisement

GCMCX vs VIMSX

Header iconGCMCX vs VIMSX Comparison
Open Charts GCMCX vs VIMSXBanner chart's image
Goldman Sachs Mid Cap Value C
Price$29.29
Change+$0.09 (+0.31%)
VolumeN/A
Net Assets1.09B
Vanguard Mid Cap Index Investor
Price$77.34
Change+$0.33 (+0.43%)
VolumeN/A
Net Assets192.45B
GCMCX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCMCX vs. VIMSX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMCX is a Buy and VIMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 192B vs. GCMCX (1.09B). VIMSX pays higher dividends than GCMCX: VIMSX (1.40) vs GCMCX (0.19). GCMCX was incepted earlier than VIMSX: GCMCX (28 years) vs VIMSX (27 years). GCMCX (1.95) is less costly to investors than VIMSX (0.17). GCMCX is a more actively managed with annual turnover of: 56.00 vs. VIMSX (16.00). GCMCX has a lower initial minimum investment than VIMSX: GCMCX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 16.95 vs. GCMCX (3.72). VIMSX return over 5 years is better than : 71.02 vs. GCMCX (18.13).
GCMCXVIMSXGCMCX / VIMSX
Total Expense Ratio1.940.171,141%
Annual Report Gross Expense Ratio1.950.171,147%
Fund Existence28 years27 years-
Gain YTD3.0356.91644%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B192B1%
Annual Yield % from dividends0.191.4014%
Returns for 1 year3.7216.9522%
Returns for 3 years1.2840.093%
Returns for 5 years18.1371.0226%
Returns for 10 years-22.22125.42-18%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSHA2.540.12
+4.96%
Taysha Gene Therapies
ACXP0.500.01
+2.35%
Acurx Pharmaceuticals
FIX535.027.60
+1.44%
Comfort Systems USA
FINW15.940.09
+0.54%
FinWise Bancorp
BANF130.050.21
+0.16%
BancFirst Corp